B. Royer-Pokora

发表

A novel C8orf37 splice mutation and genotype-phenotype correlation for cone-rod dystrophy

N. Rahner, G. Nuernberg, D. Finis, 2016, Ophthalmic genetics.

Chromosomal contacts connect loci associated with autism, BMI and head circumference phenotypes

S. Scherer, J. Rosenfeld, A. V. Vulto-van Silfhout, 2016, Molecular Psychiatry.

Bromodomain 4 inhibition leads to MYCN downregulation in Wilms’ tumor cells

Noah E. Berlow, C. Keller, J. Michalek, 2021, bioRxiv.

Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor

Noah E. Berlow, J. Michalek, A. Kung, 2021, Pediatric blood & cancer.

TO JMG STK 11 genotyping and cancer risk in Peutz-Jeghers syndrome

G. Möslein, B. Royer-Pokora, B. Leube, 2005 .

Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance

C. Evers, U. Germing, B. Royer-Pokora, 2011, Leukemia.

Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors.

T. Huang, A. Greenhough, K. Malik, 2007, Neoplasia.

A novel post-transcriptional splicing form of the acute T cell leukemia proto-oncogeneLmo2

T. Zhu, B. Royer-Pokora, G. Qin, 2001, Science in China Series C: Life Sciences.

Pathological assessment of mismatch repair gene variants in Lynch syndrome: Past, present, and future

Christopher D. Heinen, N. de Wind, L. Rasmussen, 2012, Human mutation.

A novel inverted 17p13.3 microduplication disrupting PAFAH1B1 (LIS1) in a girl with syndromic lissencephaly

B. Royer-Pokora, T. Goecke, M. Karenfort, 2013, American journal of medical genetics. Part A.

Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: A comprehensive analysis of 3,671 families

M. Loeffler, C. Engel, H. Schackert, 2014, International journal of cancer.

No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients

M. Kloor, W. Schmiegel, C. Engel, 2008, European Journal of Human Genetics.

Application of a five-tiered scheme for standardized classification of 2 , 360 unique mismatch repair gene variants lodged on the InSiGHT locus-specific database

P. Møller, L. Rasmussen, A. Spurdle, 2013 .

Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location.

A. Monaco, L. Kunkel, S. Orkin, 1986, Cold Spring Harbor symposia on quantitative biology.

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature

T. Haferlach, K. Götze, U. Germing, 2018, Oncotarget.

Heterogeneity of mitochondrial energy metabolism in classical triphasic Wilms' tumor.

N. Jones, W. Sperl, B. Kofler, 2011, Frontiers in bioscience.

Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

S. Schneider, D. Harms, B. Royer-Pokora, 1997, Proceedings of the National Academy of Sciences of the United States of America.

A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3′ third of the gene

J. Chang-Claude, P. Tonin, B. Royer-Pokora, 1998, Human Genetics.

Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study

R. Fenk, R. Haas, R. Kronenwett, 2008, Hematological oncology.

Evaluation of Chromosome 11p Imbalances in Aniridia and Wilms Tumor Patients

B. Royer-Pokora, B. Leube, A. Thiel, 2013, American journal of medical genetics. Part A.

Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin‐associated protein β1 gene CTNNB1 for patients with Wilms tumors

F. Autschbach, I. Leuschner, N. Graf, 2008 .

Quantitative real‐time reverse‐transcription polymerase chain reaction for diagnosis of BCR‐ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation

G. Kobbe, R. Fenk, R. Haas, 2003, European journal of haematology.

Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.

J. Mora, C. de Torres, H. Royer, 2010, Human molecular genetics.

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2

M. Stratton, N. Rahman, A. Shelling, 2000, British Journal of Cancer.

Direct pulsed field gel electrophoresis of Wilms' tumors shows that dna deletions in 11 p 13 are rare

A. Poustka, D. Housman, S. Ragg, 1991, Genes, chromosomes & cancer.

Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene

S. Schneider, A. Blankenagel, B. Royer-Pokora, 1994, Human Genetics.

A LINE element is present at the site of a 300-kb deletion starting in intron 10 of the PAX6 gene in a case of familial aniridia

B. Royer-Pokora, M. Drechsler, 1996, Human Genetics.

Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations

S. Schneider, B. Royer-Pokora, G. Wildhardt, 1993, Human Genetics.

Slow progressive FSGS associated with an F392L WT1 mutation

A. Jankauskienė, A. Laurinavičius, B. Royer-Pokora, 2004, Pediatric Nephrology.

Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.

R. Pollastro, K. Schärer, U. Helmchen, 1998, Kidney international.

Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin

W. Wruck, B. Royer-Pokora, M. Beier, 2022, bioRxiv.

Expression of resistance‐related proteins in nephroblastoma after chemotherapy

M. Volm, S. Schneider, J. Mattern, 1995, International journal of cancer.

Shared Copy Number Variation in Simultaneous Nephroblastoma and Neuroblastoma due to Fanconi Anemia

T. Barth, K. Mrasek, T. Liehr, 2012, Molecular Syndromology.

Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.

T. Fehr, K. Budde, M. Konrad, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Refined mapping of allele loss at chromosome 10q23‐26 in prostate cancer

T. Visakorpi, W. Schulz, R. Schäfer, 2002, The Prostate.

Par 4 is a coactivator for a splice isoform – specific transcriptional activation domain in WT 1

D. Richard, B. Royer-Pokora, V. Schumacher, 2001 .

Plasmids Controlling Synthesis of Hemolysin in Escherichia coli: Molecular Properties

H. Bujard, W. Goebel, W. Lindenmaier, 1974, Journal of bacteriology.

Isolation of UV-resistant revertants from a xeroderma pigmentosum complementation group A cell line

W. Haseltine, B. Royer-Pokora, 1984, Nature.

Recognition of HLA-A2 by cytotoxic T lymphocytes after DNA transfer into human and murine cells.

M. van de Rijn, J. Seidman, H. Spits, 1984, Science.

Fusion of H4/D10S170 to PDGFRβ in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib

U. Germing, B. Royer-Pokora, A. Kündgen, 2007, Annals of Hematology.

Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment

C. Herold, R. Haas, R. Kronenwett, 2003, Leukemia.

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.

U. Germing, G. Kobbe, R. Fenk, 2002, Experimental hematology.

160 ANALYSIS OF POSSIBLE BIOMARKERS TO PREDICT RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OR ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE

T. Haferlach, K. Götze, S. Schnittger, 2015 .

STK11 genotyping and cancer risk in Peutz-Jeghers syndrome

G. Möslein, B. Royer-Pokora, B. Leube, 2005, Journal of Medical Genetics.

The tyrosine-kinase inhibitor imatinib induces long-term remission in a patient with chronic myelogenous leukemia with translocation t(4;22)

U. Germing, R. Fenk, R. Haas, 2007, Leukemia.

Ten novel mutations found in aniridia

B. Lorenz, A. Winterpacht, M. Wolf, 1998, Human mutation.

Novel approaches for cloning human genes: the chronic granulomatous disease (CGD).

B. Royer-Pokora, 1987, Disease markers.

Spontaneous in vitro transformation of primary human osteoblast-like cells.

R. Burgkart, U. Magdolen, B. Saldamli, 2010, Cancer genomics & proteomics.

Prognostic Impact Of Molecular Mutations In 182 Patients With Myelodysplastic Syndromes

A. Kohlmann, T. Haferlach, K. Götze, 2013 .

RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.

S. Schneider, B. Royer-Pokora, B. Brenner, 1992, Oncogene.

Plasmids controlling synthesis of hemolysin inEscherichia coli

W. Goebel, B. Royer-Pokora, 1976, Molecular and General Genetics MGG.

Evidence for the multiple oncogenic potential of cloned leukemia virus: in vitro and in vitro studies with avian erythroblastosis virus.

T. Graf, H. Beug, G. Schubert, 1976, Virology.

Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells.

Carsten Denkert, Jan Budczies, Manfred Dietel, 2009, Cancer research.

Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15

J. Mora, C. de Torres, P. Jat, 2016, PloS one.

Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region

L. Strong, A. Swaroop, H. Meijers-Heijboer, 1991, Cell.

In vitro transformation with avian myelocytomatosis virus strain CMII: characterization of the virus and its target cells.

T. Graf, H. Beug, B. Royer-Pokora, 1977, Virology.

IN VITRO TRANSFORMATION OF SPECIFIC TARGET CELLS BY AVIAN LEUKEMIA VIRUSES

T. Graf, H. Beug, B. Royer-Pokora, 1976 .

Mutant avian erythroblastosis virus with restricted target cell specificity

T. Graf, H. Beug, B. Royer-Pokora, 1979, Nature.

Defectiveness of avian erythroblastosis virus: synthesis of a 75K gag-related protein.

T. Graf, M. Hayman, B. Royer-Pokora, 1979, Virology.

Transformation parameters in chicken fibroblasts transformed by AEV and MC29 avian leukemia viruses

T. Graf, H. Beug, B. Royer-Pokora, 1978, Cell.

Oncornavirus-induced sarcoma formation obscured by rapid development of lethal leukemia.

T. Graf, H. Beug, B. Royer-Pokora, 1977, Cancer research.

Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome

L. Looijenga, H. Stoop, W. Schulz, 2008, Molecular reproduction and development.

Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.

F. Eitner, I. Leuschner, J. Becker, 2007, Journal of the American Society of Nephrology : JASN.

Two molecular subgroups of Wilms' tumors with or without WT1 mutations.

J. Licht, I. Leuschner, S. Roberts, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin.

P. Wieacker, B. Royer-Pokora, R. Willers, 2000, Molecular human reproduction.

Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.

M. Stratton, J. Chang-Claude, H. Becher, 1998, Journal of medical genetics.

Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location

A. Monaco, L. Kunkel, S. Orkin, 1986, Nature.

Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities.

T. Aigner, J. Dötsch, W. Rascher, 2004, Human molecular genetics.

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

Rodney J Scott, John-Paul Plazzer, Finlay Macrae, 2013, Nature Genetics.

YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.

M. Dietel, F. Leenders, S. Bergmann, 2005, Cancer research.

Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome

S. Gruber, R. Scott, R. Houlston, 2006, Clinical Cancer Research.

Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor

Kathy Pritchard-Jones, Chris Jones, Raisa Vuononvirta, 2009, PLoS genetics.

A novel transcript of the LMO2 gene, LMO2-c, is regulated by GATA-1 and PU.1 and encodes an antagonist of LMO2

X. Wang, T. Zhu, Q. Wang, 2007, Leukemia.

TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11).

W. Ludwig, B. Royer-Pokora, U. Loos, 1991, Oncogene.

Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK)

Karl Sperling, André Reis, E. Schröck, 1994, Nature Genetics.

Genomic structure, alternative transcripts and chromosome location of the human LIM domain binding protein 1 gene LDB1

S. Friedrich, J. Bodem, B. Royer-Pokora, 1999, Cytogenetic and Genome Research.

Promoter 1 of LMO 2 , a master gene for hematopoiesis , is regulated by the erythroid specific transcription factor GATA 1

B. Royer-Pokora, M. Drechsler, M. Pruess, 2022 .

Genetic predisposition to Wilms tumor

B. Royer-Pokora, 2007 .

Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3.

Michael Krawczak, Barbara Burwinkel, Rongxi Yang, 2014, Carcinogenesis.

BASP1 Is a Transcriptional Cosuppressor for the Wilms' Tumor Suppressor Protein WT1

Matthias Mann, Stefan G. E. Roberts, Marika Charalambous, 2004, Molecular and Cellular Biology.

Biological and biochemical characterization of an SV40-transformed xeroderma pigmentosum cell line.

W. Haseltine, B. Royer-Pokora, W. D. Peterson, 1984, Experimental cell research.

Genetics of pediatric renal tumors

B. Royer-Pokora, 2012, Pediatric Nephrology.

Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH

C. Evers, U. Germing, H. Royer, 2007, Genes, chromosomes & cancer.

Comparative performance analysis of human iPSC-derived and primary neural progenitor cells (NPC) grown as neurospheres in vitro.

A. Epanchintsev, J. Adjaye, J. Egly, 2017, Stem cell research.

Mutations of p53 in Wilms' tumors.

C. Bartram, H. Koeffler, S. Schneider, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Structural chromosome abnormalities, increased DNA strand breaks and DNA strand break repair deficiency in dermal fibroblasts from old female human donors

M. Boerries, H. Busch, A. Bürkle, 2015, Aging.

Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome

Steve Hoffmann, Martin Peifer, Markus Loeffler, 2017, The Journal of pathology.

Wilms tumors arising at young age: a genetic basis to distinguish subgroups for individualized therapy.

N. Graf, B. Royer-Pokora, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity.

P. Voûte, U. Abel, I. Leuschner, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Twenty‐four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development

V. Huff, B. Royer-Pokora, V. Schumacher, 2004, American journal of medical genetics. Part A.

Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome

M. Kloor, K. Schulmann, H. Schackert, 2011, Journal of Medical Genetics.

WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.

M. Ladomery, S. Harper, D. Bates, 2011, Cancer cell.

Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations

J. Mora, H. Thiele, B. Royer-Pokora, 2020, Cancers.

WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier.

J. Zaia, U. Schlötzer-Schrehardt, H. Pavenstädt, 2011, Journal of the American Society of Nephrology : JASN.

Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.

U. Germing, B. Royer-Pokora, B. Hildebrandt, 2006, Cancer genetics and cytogenetics.

Clinical outcome and genotype in patients with hereditary multiple exostoses

M. Jäger, B. Royer-Pokora, B. Leube, 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders.

Bethan E. Hoskins, A. Bakkaloğlu, F. Hildebrandt, 2006, Kidney international.

Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2

G. Möslein, C. Konermann, H. Schaal, 2009, Journal of Cancer Research and Clinical Oncology.

SDHD mutation analysis in seven German patients with sporadic carotid body paraganglioma: one novel mutation, no Dutch founder mutation and further evidence that G12S is a polymorphism

B. Royer-Pokora, B. Leube, T. Goecke, 2003, Clinical genetics.

Molecular cloning of the translocation breakpoint in T-ALL 11;14 (p13;q11): genomic map of TCR alpha and delta region on chromosome 14q11 and long-range map of region 11p13

S. Ragg, B. Royer-Pokora, U. Loos, 1989, Human Genetics.

Correction: Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor

Chris Jones, K. Pritchard-Jones, Abby Sarkar, 2009, PLoS Genetics.

Characterization of the hematopoietic target cells of defective avian leukemia viruses by velocity sedimentation and density gradient centrifugation analyses.

T. Graf, H. Beug, E. Korzeniewska, 1981, Haematology and blood transfusion.

Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR‐18a regulation

H. Stephan, B. Royer-Pokora, K. Metz, 2017, International journal of cancer.

Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC

M. Ebert, K. Schulmann, H. Schackert, 2008, European Journal of Human Genetics.

Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib

R. Eils, B. Brors, U. Steidl, 2005, Leukemia.

Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation

E. Toska, S. Roberts, H. Royer, 2014, Human molecular genetics.

Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.

U. Germing, B. Royer-Pokora, B. Hildebrandt, 2006, Cancer genetics and cytogenetics.

Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potential.

A. Musti, S. Schneider, B. Royer-Pokora, 1997, European journal of biochemistry.

The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL).

S. Schneider, M. Rogers, B. Royer-Pokora, 1995, Oncogene.

Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

D. Richard, B. Royer-Pokora, V. Schumacher, 2001, Genes & development.

Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studies

Johannes H. Hegemann, Christoph Engel, Robin Küppers, 2011, Familial Cancer.

Hidden chromosomal aberrations are rare in primary myelodysplastic syndromes with evolution to acute myeloid leukaemia and normal cytogenetics.

U. Germing, B. Royer-Pokora, B. Hildebrandt, 2004, Leukemia research.

New approaches to DNA damage and repair: the ultraviolet light example.

W. Haseltine, D. Brash, J. Lippke, 1982, Basic life sciences.

Ulna/height ratio as clinical parameter separating EXT1 from EXT2 families?

M. Jäger, B. Royer-Pokora, B. Leube, 2008, Genetic testing.

[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].

J. Rüschoff, R. Büttner, A. Tannapfel, 2014, Zentralblatt fur Chirurgie.

Response to: Design of a Core Classification Process for DNA Mismatch Repair Variations of A Priori Unknown Functional Significance

L. Rasmussen, S. Tavtigian, R. Hofstra, 2013, Human mutation.

Adjuvant chemotherapy (ACT) in stage II colon cancer (CC) in patients with Lynch syndrome.

K. Schulmann, W. Schmiegel, C. Engel, 2012 .

Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examples.

W. Haseltine, B. Royer-Pokora, L. Gordon, 1981, Nucleic acids research.

WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1.

J. Mora, C. de Torres, B. Royer-Pokora, 2019, Journal of pediatric hematology/oncology.

A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer

A. Lindblom, P. Sasieni, I. Bernstein, 2014, International journal of cancer.

Plasmids controlling synthesis of hemolysin in Escherichia coli. II. Polynucleotide sequence relationship among hemolytic plasmids.

W. Goebel, B. Royer-Pokora, 1976, Molecular & general genetics : MGG.

The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1.

M. von Knebel Doeberitz, C. Engel, H. Schackert, 2007, Cancer letters.

Chemotherapy and terminal skeletal muscle differentiation in WT1‐mutant Wilms tumors

J. Mora, C. de Torres, H. Royer, 2018, Cancer medicine.

The additive effect of p 53 Arg 72 Pro and RNASEL Arg 462 Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH 2 or MLH 1

C. Engel, H. Schackert, S. Krüger, 2007 .

Characterization of the transcriptional regulatory region of the human WT1 gene.

W. Hofmann, S. Schneider, H. Royer, 1993, Oncogene.

STK11 status and intussusception risk in Peutz-Jeghers syndrome

S. Gruber, R. Scott, R. Houlston, 2006, Journal of Medical Genetics.

Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation

J. Mora, C. de Torres, B. Royer-Pokora, 2007, Journal of Medical Genetics.

Tissue restricted expression and chromosomal localization of the YB-1 gene encoding a 42 kD nuclear CCAAT binding protein.

N. Copeland, D. Gilbert, N. Jenkins, 1992, Nucleic acids research.

Germline Wilms tumor suppressor gene (WT1) mutation leading to isolated genital malformation without Wilms tumor or nephropathy.

A. Grüters, B. Köhler, B. Royer-Pokora, 2001, The Journal of pediatrics.

A single ancestral gene of the human LIM domain oncogene family LMO in Drosophila: characterization of the Drosophila Dlmo gene.

R. Paro, J. Bodem, B. Royer-Pokora, 1995, Oncogene.

Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour

S. Seal, M. Stratton, N. Rahman, 2005, Journal of Medical Genetics.

Effective use of high-dose chemotherapy and autologous stem cell rescue for relapsed adult Wilms' tumor and a novel alteration in intron 1 of the WT1 gene.

B. Dörken, J. Zuber, B. Hildebrandt, 2004, Journal of pediatric hematology/oncology.

Refined mapping of allele loss at chromosome 10q23‐26 in prostate cancer

T. Visakorpi, W. Schulz, R. Schäfer, 2002, The Prostate.

Analysis of native WT1 protein from frozen human kidney and Wilms' tumors

S. Iben, B. Royer-Pokora, 1999, Oncogene.

Bilateral Wilms Tumor in a Boy with Severe Hypospadias and Cryptorchidism Due to a Heterozygous Mutation in the WT1 Gene

A. Grüters, B. Köhler, B. Royer-Pokora, 1999, Pediatric Research.

Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5 q 31 in Wilms ’ Tumor

Anthony R. Dallosso, Chris Jones, K. Pritchard-Jones, 2009 .

Localization of the human CD59 gene by fluorescence in situ hybridization and pulsed-field gel electrophoresis.

H. Scherthan, S. Ragg, B. Royer-Pokora, 1993, Cytogenetics and Cell Genetics.

Wilms' tumor‐specific methylation pattern in 11p13 detected by PFGE

S. Schneider, B. Royer-Pokora, Brigitte Royer‐Pokora, 1992, Genes, chromosomes & cancer.

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2

N. Rahman, A. Shelling, W. Foulkes, 2000, British Journal of Cancer.

Tumor specificity of acute avian leukemia viruses reflected by their transformation target cell specificity in vitro

T. Graf, H. Beug, B. Royer-Pokora, 2005, Medical Microbiology and Immunology.

Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region

L. Strong, A. Swaroop, H. Meijers-Heijboer, 1991, Cell.

WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier.

J. Zaia, U. Schlötzer-Schrehardt, H. Pavenstädt, 2011, Journal of the American Society of Nephrology : JASN.

Target cells for transformation with avian leukosis viruses.

B. Royer-Pokora, Thomas Graf, Hartmut Beug, 1976, Hamatologie und Bluttransfusion.